UB
CORT icon

UMB Bank’s Corcept Therapeutics CORT Stock Holding History

UMB Bank’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.2K Buy
658
+54
+9% +$3.26K ﹤0.01% 1266
2026
Q1 		$24.3K Buy
604
+84
+16% +$3.14K ﹤0.01% 1527
2025
Q4 		$18.1K Buy
520
+93
+22% +$7.3K ﹤0.01% 1597
2025
Q3 		$35.5K Buy
427
+72
+20% +$5.21K ﹤0.01% 1264
2025
Q2 		$26.1K Buy
355
+21
+6% +$1.52K ﹤0.01% 1306
2025
Q1 		$38.1K Buy
334
+107
+47% +$6.51K ﹤0.01% 1159
2024
Q4 		$11.4K Hold
227
– – ﹤0.01% 1428
2024
Q3 		$10.5K Buy
227
+123
+118% +$4.37K ﹤0.01% 1468
2024
Q2 		$3.38K Buy
104
+65
+167% +$1.78K ﹤0.01% 1575
2024
Q1 		$982 Buy
+39
New +$921 ﹤0.01% 1780

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's CORT Position: Q2 2026 in Review

UMB Bank increased its Corcept Therapeutics (CORT) stake by 8.9% in Q2 2026, buying an estimated $3.26K and bringing the position to 658 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

UMB Bank first reported a position in CORT in Q1 2024 and has held it in 10 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • UMB Bank held 658 shares of Corcept Therapeutics worth $57.2K as of Q2 2026.
  • UMB Bank bought 54 Corcept Therapeutics shares in Q2 2026, an estimated $3.26K.
  • Corcept Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1266 holding.
  • UMB Bank first reported a position in Corcept Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.